Mannkind (MNKD) Non-Current Debt (2010 - 2026)
Mannkind (MNKD) reported Non-Current Debt of $92.8 million for Q1 2026, down 0.94% year-over-year from $93.7 million in Q1 2025, and little changed on a QoQ basis from $93.1 million in Q4 2025.
Mannkind (MNKD) has 17 years of Non-Current Debt data on file, last reported at $92.8 million in Q1 2026.
- Quarterly Non-Current Debt fell 0.94% year-over-year to $92.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.8 million (down 0.94% YoY) and the FY2025 annual result came in at $93.1 million, down 0.84% from the prior year.
- Non-Current Debt steadied at $92.8 million in Q1 2026 per MNKD's latest filing, from $93.1 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $94.3 million in Q4 2023 and bottomed at $8.8 million in Q4 2022.
- The 5-year median for Non-Current Debt is $93.3 million (2025), against an average of $70.8 million.
- The widest annual swing landed in 2023, when Non-Current Debt jumped 968.07%; it then slipped 21.89% in 2025.
- Tracing MNKD's Non-Current Debt over 5 years: stood at $8.8 million in 2022, then jumped by 968.07% to $94.3 million in 2023, then slipped by 0.45% to $93.9 million in 2024, then fell by 0.84% to $93.1 million in 2025, then retreated by 0.33% to $92.8 million in 2026.
- Per Business Quant, the three latest MNKD Non-Current Debt figures stand at $92.8 million (Q1 2026), $93.1 million (Q4 2025), and $73.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 105.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 92.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.78 Mn |
| Mar 31, 2026 | 92.78 Mn |
| Dec 31, 2025 | 93.09 Mn |
| Dec 31, 2025 | 93.09 Mn |
| Sep 30, 2025 | 73.43 Mn |
| Sep 30, 2025 | 73.43 Mn |
| Jun 30, 2025 | 93.50 Mn |
| Jun 30, 2025 | 93.50 Mn |
| Mar 31, 2025 | 93.67 Mn |
| Mar 31, 2025 | 93.67 Mn |
| Dec 31, 2024 | 93.88 Mn |
| Dec 31, 2024 | 93.88 Mn |
| Sep 30, 2024 | 94.00 Mn |
| Sep 30, 2024 | 94.00 Mn |
| Jun 30, 2024 | 94.10 Mn |
| Jun 30, 2024 | 94.10 Mn |
| Dec 31, 2023 | 94.30 Mn |
| Dec 31, 2023 | 94.30 Mn |
| Sep 30, 2023 | 8.83 Mn |
| Sep 30, 2023 | 8.83 Mn |
| Jun 30, 2023 | 8.83 Mn |
| Jun 30, 2023 | 8.83 Mn |
| Dec 31, 2022 | 8.83 Mn |
| Dec 31, 2022 | 8.83 Mn |
| Mar 31, 2021 | 203,000.00 |
| Mar 31, 2021 | 203,000.00 |
| Dec 31, 2020 | 812,000.00 |
| Dec 31, 2020 | 812,000.00 |
| Sep 30, 2020 | 1.42 Mn |
| Sep 30, 2020 | 1.42 Mn |
| Jun 30, 2020 | 2.03 Mn |
| Jun 30, 2020 | 2.03 Mn |
| Jun 30, 2019 | 71.98 Mn |
| Jun 30, 2019 | 71.98 Mn |
| Mar 31, 2019 | 72.04 Mn |
| Mar 31, 2019 | 72.04 Mn |
| Dec 31, 2018 | 72.09 Mn |
| Dec 31, 2018 | 72.09 Mn |
| Sep 30, 2018 | 72.14 Mn |
| Sep 30, 2018 | 72.14 Mn |
| Jun 30, 2018 | 72.20 Mn |
| Jun 30, 2018 | 72.20 Mn |
| Mar 31, 2018 | 72.25 Mn |
| Mar 31, 2018 | 72.25 Mn |
| Dec 31, 2017 | 79.67 Mn |
| Dec 31, 2017 | 79.67 Mn |
| Sep 30, 2017 | 79.67 Mn |
| Sep 30, 2017 | 79.67 Mn |
| Jun 30, 2017 | 79.67 Mn |
| Jun 30, 2017 | 79.67 Mn |
| Mar 31, 2017 | 49.52 Mn |
| Mar 31, 2017 | 49.52 Mn |
| Dec 31, 2016 | 49.52 Mn |
| Dec 31, 2016 | 49.52 Mn |
| Sep 30, 2016 | 49.52 Mn |
| Sep 30, 2016 | 49.52 Mn |
| Jun 30, 2016 | 49.52 Mn |
| Jun 30, 2016 | 49.52 Mn |
| Mar 31, 2016 | 49.52 Mn |
| Mar 31, 2016 | 49.52 Mn |
| Dec 31, 2015 | 49.52 Mn |
| Dec 31, 2015 | 49.52 Mn |
| Sep 30, 2015 | 49.52 Mn |
| Sep 30, 2015 | 49.52 Mn |
| Jun 30, 2015 | 49.52 Mn |
| Jun 30, 2015 | 49.52 Mn |
| Mar 31, 2015 | 49.52 Mn |
| Mar 31, 2015 | 49.52 Mn |
| Dec 31, 2014 | 49.52 Mn |
| Dec 31, 2014 | 49.52 Mn |
| Sep 30, 2014 | 72.63 Mn |
| Sep 30, 2014 | 72.63 Mn |
| Jun 30, 2014 | 49.52 Mn |
| Jun 30, 2014 | 49.52 Mn |
| Mar 31, 2014 | 49.52 Mn |
| Mar 31, 2014 | 49.52 Mn |
| Dec 31, 2013 | 18.40 Mn |
| Dec 31, 2013 | 18.40 Mn |
| Sep 30, 2013 | 119.64 Mn |
| Sep 30, 2013 | 119.64 Mn |
| Dec 31, 2012 | 119.64 Mn |
| Dec 31, 2012 | 119.64 Mn |
| Sep 30, 2012 | 223.14 Mn |
| Sep 30, 2012 | 223.14 Mn |
| Jun 30, 2012 | 218.14 Mn |
| Jun 30, 2012 | 218.14 Mn |
| Mar 31, 2012 | 283.45 Mn |
| Mar 31, 2012 | 283.45 Mn |
| Dec 31, 2011 | 277.20 Mn |
| Dec 31, 2011 | 277.20 Mn |
| Sep 30, 2011 | 277.20 Mn |
| Sep 30, 2011 | 277.20 Mn |
| Jun 30, 2011 | 242.20 Mn |
| Jun 30, 2011 | 242.20 Mn |
| Dec 31, 2010 | 235.32 Mn |
| Dec 31, 2010 | 235.32 Mn |